Two-Years Corneal Collagen Cross-Linking Outcomes in Patients with Keratoconus

Aims: This study aimed to report refractive, topographic, and tomographic outcomes of 2-years corneal collagen cross-linking in patients with progressive keratoconus. Materials and Method: This prospective study was conducted on76 eyes of 40 patients with progressive keratoconus and a corneal thickness of at least 400?m. After the baseline examination, cross-linking was performed using riboflavin 0.1% and ultraviolet irradiation (370 nm, 3 mW/cm2) for 30 min. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction spherical equivalent (MRSE), cylinder, keratometric readings, and corneal thickness were evaluated at baseline, 6, 12, and 24 months after corneal collagen cross-linking. Results: Results showed that at a 24-month follow-up, mean BSCVA, and UCVA had significant improvements. Changes in MRSE and cylinder were not significant during the two years of follow-up. At a 2-years follow-up, the mean values of minimum keratometry, maximum keratometry, and average keratometry decreased significantly to0.75, 0.97, and 0.52 D, respectively, compared to their baseline values. Anterior best fit sphere (BFS) also had significant difference at 24-month follow-up compared to base line evaluation. The central corneal thickness decreased significantly up to38 ? after 2 years. Conclusion: Corneal collagen cross-linking is an effective treatment to stop the progression of keratoconusas shown by reduced keratometry and improved vision.

[1]  A. Jaiswal,et al.  Indian Journal of Forensic Medicine & Toxicology , 2013 .

[2]  C. Uiterwaal,et al.  Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study. , 2017, American journal of ophthalmology.

[3]  M. Belin,et al.  Intereye Asymmetry in Eyes With Keratoconus and High Ammetropia: Scheimpflug Imaging Analysis , 2015, Cornea.

[4]  William J Dupps,et al.  Biomechanics of corneal ectasia and biomechanical treatments. , 2014, Journal of cataract and refractive surgery.

[5]  T. Sengor,et al.  Vision Related Quality of Life in Patients with Keratoconus , 2014, Journal of ophthalmology.

[6]  D. Viswanathan,et al.  Prospective longitudinal study of corneal collagen cross‐linking in progressive keratoconus , 2013, Clinical & experimental ophthalmology.

[7]  A. Fotouhi,et al.  Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results. , 2013, Ophthalmology.

[8]  T. M. El-Raggal Sequential versus concurrent KERARINGS insertion and corneal collagen cross-linking for keratoconus , 2010, British Journal of Ophthalmology.

[9]  T. M. El-Raggal Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus , 2009, Middle East African journal of ophthalmology.

[10]  R. Vinciguerra,et al.  Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. , 2009, Ophthalmology.

[11]  Paulo Schor,et al.  Ultra B2 - Promoção de ligações covalentes do colágeno corneal (Corneal cross-linking) no tratamento de ceratocone: resultados preliminares , 2008 .

[12]  Ecosse Lamoureux,et al.  A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. , 2008, Journal of refractive surgery.

[13]  E. Spoerl,et al.  [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas]. , 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[14]  T. Seiler,et al.  Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis , 2007, Journal of cataract and refractive surgery.

[15]  M. Kanavi,et al.  Indications for Penetrating Keratoplasty in Iran , 2007, Cornea.

[16]  Theo Seiler,et al.  Safety of UVA-Riboflavin Cross-Linking of the Cornea , 2007, Cornea.

[17]  Cristina Tommasi,et al.  Treatment of Progressive Keratoconus by Riboflavin-UVA-Induced Cross-Linking of Corneal Collagen: Ultrastructural Analysis by Heidelberg Retinal Tomograph II In Vivo Confocal Microscopy in Humans , 2007, Cornea.

[18]  T. Oshika,et al.  Longitudinal Changes in Corneal Irregular Astigmatism and Visual Acuity in Eyes with Keratoconus , 2005, Japanese Journal of Ophthalmology.

[19]  G. Wollensak,et al.  Crosslinking treatment of progressive keratoconus: new hope , 2006, Current opinion in ophthalmology.

[20]  Eberhard Spoerl,et al.  Biomechanical evidence of the distribution of cross‐links in corneastreated with riboflavin and ultraviolet A light , 2006, Journal of cataract and refractive surgery.

[21]  T. Seiler,et al.  Collagen Fiber Diameter in the Rabbit Cornea After Collagen Crosslinking by Riboflavin/UVA , 2004, Cornea.

[22]  A. Cassels-Brown,et al.  Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients , 2004, Eye.

[23]  Theo Seiler,et al.  Keratocyte Apoptosis After Corneal Collagen Cross-linking Using Riboflavin/UVA Treatment , 2004, Cornea.

[24]  Theo Seiler,et al.  Increased resistance of crosslinked cornea against enzymatic digestion , 2004, Current eye research.

[25]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[26]  E. Spörl,et al.  Untersuchungen zur Verfestigung der Hornhaut am Kaninchen , 2000, Der Ophthalmologe.

[27]  J. Naor,et al.  Three decades of corneal transplantation: indications and patient characteristics. , 2000, Cornea.

[28]  J. Sugar,et al.  Lysosomal enzyme abnormalities in keratoconus. , 1989, Archives of ophthalmology.

[29]  W. M. Bourne,et al.  A 48-year clinical and epidemiologic study of keratoconus. , 1986, American journal of ophthalmology.

[30]  W. Kao,et al.  Increased collagenase and gelatinase activities in keratoconus. , 1982, Biochemical and biophysical research communications.

[31]  M. Lahav,et al.  Collagenolytic activity in keratoconus. , 1982, Annals of ophthalmology.